Resources
Behavioral Wellness for Women is happy to share free perinatal health resources.
-
-
PSI Hotline: 1-800-944-4773
-
Call or text 1-833-852-6262
(1-833-TLC-MAMA)
-
Call 1-800-273-TALK (1-800-273-8255) Call or text 988
*If you need immediate help, please call 911 or go to the nearest emergency room.
-
Knowns and Unknowns About SSRI Use During Pregnancy in 2022
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women’s Mental Health at Massachusetts General Hospital, recently shared his insights on clinical issues regarding prescribing antidepressants during pregnancy with Ob.Gyn News on March 23, 2022.
Largest Study Ever Shows No Increase in Risk of Neurodevelopmental Disorders in Kids Exposed to Antidepressants In Utero
Analyzing data from nearly 150,000 children with prenatal antidepressant exposure in two healthcare databases, a recent study finds no association between prenatal exposure to antidepressants and risk for neurodevelopmental disorders.
No Link Between Prenatal Exposure to Antidepressants and Risk for ADHD in Offspring
While previous studies have reported an association between antidepressant use during pregnancy and increased risk of attention-deficit/hyperactivity disorder (ADHD) in the exposed offspring, one important limitation of these studies is that they often did not adequately control for potential confounding factors.
Reassuring Data on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antipsychotic Medications
Two recent studies — both of them from Denmark — add to the medical literature and provide reassuring information to women using this class of medications.
Essential Reads: SSRI Antidepressants Do Not Increase Risk of Miscarriage
A meta-analysis published in JAMA Psychiatry analyzed data from a total of 11 studies assessing pregnancy outcomes in women taking antidepressant medications during pregnancy. This meta-analysis, the largest to date, demonstrated no significant association between antidepressant exposure and risk for spontaneous abortion.